Cite Filings / RIGL / 0000093751-26-000084
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

RIGEL PHARMACEUTICALS INC · Filed 2026-02-09 · Acc 0000093751-26-000084

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-05-07 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-12 4 EVP & Chief Financial Officer gave up 3,546 shares (to pay taxes)
  • 2026-02-12 4 EVP, Chief Medical Officer gave up 3,758 shares (to pay taxes)
  • 2026-02-12 4 EVP, GC, CCO & Corp Sec gave up 3,546 shares (to pay taxes)
  • 2026-02-12 4 CEO, President gave up 7,607 shares (to pay taxes)
  • 2026-02-09 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-05 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Armistice Capital, LLC 8.22%
  2. 2026-11-16 SCHEDULE 13G · American Century Investment Management, Inc. 5.6%
  3. 2026-11-13 SCHEDULE 13G · Morgan Stanley 6.5%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…